Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis
Jesko Momotow,Ina Buehnen,Karolin Trautmann-Grill,Guido Kobbe,Dennis Hahn,Roland Schroers,Bernhard Heinrich,Tobias Gaska,Helmut Forstbauer,Burkhard Schmidt, Regina Boger,Andreas Huettmann,Gerhard Heil,Doris M. Kraemer,William Krueger,Vanja Zeremski,Norbert Grobe,Kathleen Jentsch-Ullrich,Frank Griesinger,Michael Fuchs,Bastian von Tresckow,Peter Borchmann,Andreas Engert,Paul J. Broeckelmann BRITISH JOURNAL OF HAEMATOLOGY（2022）
关键词
anti-programmed death 1, checkpoint inhibition, Hodgkin lymphoma, real-world, relapsed, refractory
AI 理解论文
溯源树
样例
